Hair growth gel vs minoxidil for male and female hair loss
Treatments studied
Part of Skin clinical trials.
This trial tests a new gel made from a natural sugar molecule against a standard hair loss treatment (minoxidil). It aims to see which works better for people with mild to moderate hereditary hair loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have been diagnosed with hereditary hair loss (male or female pattern baldness).
- Your hair loss is mild to moderate (not severe).
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You do not have other scalp conditions like psoriasis or inflammation.
- You have not had chemotherapy in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for male pattern baldness (androgenic alopecia). It is for men with a moderate level of hair loss who have not used any hair loss treatments in the last 90 days.
This study compares two forms of minoxidil (a topical liquid you apply to the scalp versus a pill you take by mouth) to see which works better for treating pattern hair loss. You will receive one of the two treatments, and the study will track how your hair responds over time.
This study tests an experimental treatment using a substance made from your own hair follicles to see if it can help regrow hair in people with pattern baldness. It involves getting several small injections into your scalp over time.
This trial tests a treatment made from umbilical cord stem cell exosomes for young men with male pattern baldness. It aims to see if this natural substance can help regrow hair.
This study tests whether giving minoxidil solution through the skin using a gentle electric current (a method called iontophoresis) can help regrow hair in people with pattern hair loss. It may offer a more effective way to deliver the treatment directly to the scalp.
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
Hear when a new Androgenic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.